8-K
Current Report
Alaunos Therapeutics, Inc. Filed Acc 0001193125-19-200629
Unregistered share sale · Executive or director change
- Item 3.02 Unregistered sales of equity securities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d767395d8k.htm…